🏛️ Verified NIH Record • Updated 2026-01-08
Study of MAR002 in Healthy Men (NCT07195175)
First in Human, Randomized, Blinded, Placebo-Controlled Single Ascending Dose and Multiple Dose Study of MAR002 in Healthy Men
🟢 Recruiting Phase1 💊 Investigational Drug / Biologic Sponsor: Marea Therapeutics
🩺 Plain-English Summary (8th-Grade Level)
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Who can join: Review the eligibility criteria below.
Location: Marea Site — Tempe, Arizona
Age range: 18 Years to 40 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Marea Site — Tempe, Arizona
📞 Contact the Study Coordinator
Phone: (415) 766-3610
Email: mar-201-info@mareatx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Acromegaly
- A Study to Evaluate MAR002 for Acromegaly — Phoenix, Arizona
- A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs — Los Angeles, California
Explore by condition: All Acromegaly clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.